ОТНОСТНО ТОЗИ ЕПИЗОД
Host: John Buse, MD, PhD
Guest: Steven Russell, MD, PhD
Guest: Steven Russell, MD, PhD
Research continues to emerge on the bionic pancreas and its capabilities, and a recent study shows how it can count carbohydrates and lower A1c for patients with type 1 diabetes. To find out how it does, Dr. John Buse is joined by Dr. Steven Russell, an Associate Professor of Medicine at Harvard Medical School at the Massachusetts General Hospital.
Английски
САЩ
В ТОЗИ ЕПИЗОД
ТРАНСКРИПЦИЯ 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ
Търсене в минали епизоди на Diabetes Discourse.
ДРУГИ ЕПИЗОДИ В ТОЗИ ПОДКАСТ
Guest: Kimberly Narain, MD, MPH, PhD
Cost-related medication nonadherence remains a significant but often hidden barrier to effective diabetes care, with out-of-pocket costs preventing patients from accessing essential therapies. Dr. Kimberly Narain joins us to explain why clinicians sho…
Host: Steve Jackson, PharmD
Guest: Souptik Barua, PhD
Guest: Emily Johnston, MPH, PhD
Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this conversation with Dr. Steve Jackson, Dr. Emily Johnston an…
Guest: John W. Ostrominski, MD, MPH
Despite advances in glycemic management, blood pressure control, lipid lowering, and disease-modifying therapies, patients with chronic kidney disease (CKD) and type 2 diabetes continue to face substantial residual cardiovascular risk. In this program,…
Guest: Javier Morales, MD, FACP, FACE
For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales sha…
Guest: Javier Morales, MD, FACP, FACE
From proactive screening to once-weekly insulin, the treatment landscape for type 1 diabetes is evolving rapidly. Join Dr. Javier Morales to hear about current and emerging care strategies in these patients, a topic he also discussed at the 2026 Amer…
Опровержение: Подкастът и произведенията на изкуството, вградени на тази страница, са от ReachMD, което е собственост на неговия собственик и не е свързано с или одобрено от Listen Notes, Inc.
РЕДАКТИРАНЕ
Благодарим Ви, че помогате да поддържаме базата данни за подкастове актуална.
